TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Urogyn Sverige AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/08 |
| Turnover |
4,467
|
5,272
|
3,836 |
| Financial expenses |
721
|
64
|
17 |
| Earnings before taxes |
-9,093
|
-508
|
4,547 |
| EBITDA |
-46,687
|
-41,798
|
-18,320 |
| Total assets |
24,704
|
21,615
|
16,439 |
| Current assets |
5,908
|
6,535
|
9,681 |
| Current liabilities |
8,192
|
7,486
|
2,604 |
| Equity capital |
1,778
|
9,318
|
12,545 |
| - share capital |
103
|
101
|
92 |
| Employees (average) |
6
|
23
|
14 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/08 |
| Solvency |
7.2%
|
43.1%
|
76.3% |
| Turnover per employee |
744
|
229
|
274 |
| Profit as a percentage of turnover |
-203.6%
|
-9.6%
|
118.5% |
| Return on assets (ROA) |
-33.9%
|
-2.1%
|
27.8% |
| Current ratio |
72.1%
|
87.3%
|
371.8% |
| Return on equity (ROE) |
-511.4%
|
-5.5%
|
36.2% |
| Change turnover |
-900
|
1,047
|
744 |
| Change turnover % |
-17%
|
25%
|
24% |
| Chg. No. of employees |
-17
|
9
|
1 |
| Chg. No. of employees % |
-74%
|
64%
|
8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.